Company Filing History:

12 out of 329

Yamanouchi Pharmaceutical Company Ltd.

patents

Ferring-research Limited

patent

where one patent can have more than one assignee

Years Active: 1990-1999

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 5962451 - Benzodiazepin derivatives useful as CCK-receptor antagonists (1999-10-05),

2. 5834499 - 5-HT.sub.3 receptor agonist, novel thiazole derivative and intermediate (1998-11-10),

3. 5728829 - Process of preparing benzodiazepine compounds useful as antagonists of (1998-03-17),

4. 5688943 - Benzodiazepine derivatives useful as CCK-receptor antagonists (1997-11-18),

5. 5656637 - Thiazole derivatives (1997-08-12),

6. 5565479 - Condensed thiazole derivative, production process thereof and (1996-10-15),

7. 5547961 - Method of treatment of intestinal diseases (1996-08-20),

8. 5496942 - 5-substituted tetrahydrobenzimidazole compounds (1996-03-05),

9. 5424431 - Thiazole derivatives (1995-06-13),

10. 5344927 - Tetrahydrobenzimidazole derivatives and pharmaceutical compositions (1994-09-06),

11. 5336679 - Tetrahydroimidazopyridine derivatives and salts thereof (1994-08-09),

12. 4977175 - 4,5,6,7-tetrahydrobenzimidazole derivatives as 5HT.sub.3 -antagonists (1990-12-11),

Title: Keiji Miyata: Innovator in Pharmaceutical Chemistry

Introduction

Keiji Miyata is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 12 patents to his name, he has made remarkable advancements in the field of medicinal compounds.

Latest Patents

One of his latest patents includes the development of benzodiazepine derivatives that serve as CCK-receptor antagonists. This innovative compound features a specific formula where R1 is either a CH2 CHOH(CH2)a R4 or a ketone group CH2 CO(CH2)a R5, with a and R4 and R5 being selected from various alkyl and cycloalkyl groups. Additionally, R2 and R3 are independently chosen from aromatic carbocyclic and heterocyclic residues, while W and X can be halogen, hydrogen atoms, alkyl, or alkoxy groups. These compounds are recognized for their role as gastrin and/or CCK-B receptor antagonists.

Career Highlights

Throughout his career, Keiji Miyata has worked with notable companies such as Yamanouchi Pharmaceutical Company Ltd. and Ferring B.V. His work has significantly impacted the development of new therapeutic agents.

Collaborations

Keiji has collaborated with esteemed colleagues, including Mitsuaki Ohta and Isao Yanagisawa, contributing to various innovative projects in the pharmaceutical sector.

Conclusion

Keiji Miyata's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new medicinal compounds that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.